Cargando…
Factors associated with serum CA125 level in women without ovarian cancer in the United States: a population-based study
BACKGROUND: Cancer antigen 125 (CA125) is clinically used to monitor response to therapy in ovarian cancer and has been proposed for use in detecting ovarian cancer. This population-based study examines how demographic characteristics, gynecologic/reproductive history, chronic non-malignant medical...
Autores principales: | Hu, Xiao, Zhang, Jingzhou, Cao, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107191/ https://www.ncbi.nlm.nih.gov/pubmed/35568827 http://dx.doi.org/10.1186/s12885-022-09637-7 |
Ejemplares similares
-
CA125-Tn ELISA assay improves specificity of pre-operative diagnosis of ovarian cancer among patients with elevated serum CA125 levels
por: Wang, Yi-Sheng, et al.
Publicado: (2021) -
Preoperative LMR and Serum CA125 Level as Risk Factors for Advanced Stage of Ovarian Cancer
por: Tang, Ying, et al.
Publicado: (2021) -
The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study
por: Bai, Huimin, et al.
Publicado: (2016) -
Ovarian fibroma/fibrothecoma with elevated serum CA125 level: A cohort of 66 cases
por: Shen, Yuanming, et al.
Publicado: (2018) -
Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)